Pharma Funding and M&A in 2020

Pharma deal value not only increased in 2019, but the top ten transactions announced in the first six months of last year alone reached a total value of 47% higher than the top ten deals in the first half of 2018. What’s more, this is a continuation of a long-term trend. Over the last five years, the pharma sector has seen over 400 mergers and acquisitions, especially within the sub-sectors of gene therapy, immune-oncology and orphan drugs therapeutic categories.

Read the full article: Pharma Funding and M&A in 2020 //


Scroll to Top